Running projects
A number of projects are currently running at InGell Labs both strategically and customer oriented:
- Screening the potential of "InGell Gamma" towards controlled release of various relevant bioactive molecules (small molecules, peptides and proteins);
- Stretching the potential of "InGell Gamma" towards controlled release of hydrophilic proteins for a period up to 3 months or more;
- Intra-articular injection of hydrogels loaded with anti-inflammatory compounds for treatment of osteo-arthritis;
- Intervertebral disc regeneration by intra-disc injection of hydrogels with anti-inflammatory compounds or proteins;
- Working towards long-term systemic delivery formulations of small molecules and peptides;
- General dosing and shelving strategies;
- Scaling up and cGMP routing for the polymers;
- Shelf-life and biostability/biodegradation studies.